ProKidney Corp (NASDAQ:PROK) has a beta value of 1.39 and has seen 2.01 million shares traded in the recent trading session. The company, currently valued at $172.58M, closed the recent trade at $2.70 per share which meant it lost -$0.49 on the day or -15.36% during that session. The PROK stock price is -400.37% off its 52-week high price of $13.51 and 58.52% above the 52-week low of $1.12. The 3-month trading volume is 788.17K shares.
ProKidney Corp (NASDAQ:PROK) trade information
Sporting -15.36% in the red today, the stock has traded in the red over the last five days, when the PROK stock price touched $2.70 or saw a rise of 29.13%. Year-to-date, ProKidney Corp shares have moved 51.69%, while the 5-day performance has seen it change -10.89%. Over the past 30 days, the shares of ProKidney Corp (NASDAQ:PROK) have changed 3.45%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ProKidney Corp (PROK) estimates and forecasts
Figures show that ProKidney Corp shares have underperformed across the wider relevant industry. The company’s shares have gained 49.17% over the past 6 months, with this year growth rate of -7.02%, compared to 14.30% for the industry.
PROK Dividends
ProKidney Corp is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
